Market Research Reports
Resources
About
Cart (0)

Organ and Tissue Transplantation and Alternatives

Report Code: HLC012D

Publish Date: Oct 2008

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The U.S. market for organ and tissue transplantation and alternatives was worth $18.9 billion in 2007. The market is projected to grow to $20.9 billion in 2008 and $28.2 billion in 2013, representing a compound annual growth rate (CAGR) of 6.1%.
  • The solid organ segment has the largest share of the market, worth $9.7 billion in 2007 and an estimated $10.5 billion in 2008. This is expected to grow at a CAGR of 5.7% to reach $13.8 billion in 2013.
  • Tissue transplantation generated $9.2 billion in 2007. This should increase to $10.4 billion in 2008 and $14.3 billion in 2013, for a CAGR of 6.5%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

The objective of this study is to provide an in-depth analysis and forecast of the solid organ and tissue transplantation markets. The focus is on products and procedures used or under development for organ and tissue transplantations, including techniques, therapies, drugs, and diagnostics.
 
REASONS FOR DOING THE STUDY
 
Organ transplantation is a dynamic field, with continued progress being made in artificial organs and transplantation methods that reduce rejection and infection. There is increased pressure to perfect transplantation methods because the need for organ donors far outstrips the availability of organs and tissues and governmental regulations have become more stringent. In theory, transplantation is the last therapeutic option available to people in the final stage of an organ or tissue failure. In reality, the supply of organs or tissues is so limited that for the vast majority of people, transplantation is not an option.
 
Despite the lack of organs, the transplantation business continues to innovate through better harvesting and procurement techniques, vastly improved immunosuppression regimes, and advanced tissue matching, which have helped build the organ and tissue transplantation business to a maturing stage. This report will focus on procurement, transplantation by organ, immunosuppressives and other pharmaceuticals, post-transplantation concerns, and alternatives to transplantation. 
Although the organ transplantation business faces tough challenges, it also offers exciting fields of research and tremendous opportunities to meet growing market demand and to cut costs. This report is a valuable tool for anyone assessing the organ and tissue transplantation market and attempting to devise a strategy to successfully address it.  
 
INTENDED AUDIENCE 
 
This study provides a thorough background on the structure of the organ and tissue transplantation market and the chief issues it faces. It offers the information needed to understand the current market and to address the emerging one. This is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investing consultants, and others interested in the tissue and transplantation market, its products, its participants, and its future.  
 
SCOPE OF REPORT
 
This report offers forecasts by product segment from 2008 through 2013, including supporting analyses for projections.  
 
Product segments covered consist of solid organs (e.g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation market (e.g., bone, skin, cornea, heart valves), along with the pharmaceuticals that accompany each market. Also included are experimental xenografts and artificial organs; tissue transplants; and cell transplants (e.g., bone marrow, cord blood, peripheral blood, islet cell). The report touches on the use of fetal cells, stem cells, and altered cancer cells. 
 
The arrangement of this report offers an overview of the organ and tissue transplantation market accompanied by analyses and forecasts for each product type and application.
 
International markets are discussed, and information is provided on industry structure and the regulatory environment. Profiles of leading companies involved with tissue transplantation provide information on placement within the market and strategic analyses of the companies’ available and emerging products.  
 
This report cites autologous products only in relation to their impact on the market for allografts. It does not include blood products, with the exception of peripheral and umbilical cord blood as a source of stem cells.
 
METHODOLOGY
 
Information for this report was derived from a variety of primary and secondary research sources, including industry analysts, transplant surgeons, and pertinent societies’ and associations’ representatives. Additional data was derived from companies’ annual reports and 10Ks, journal articles, prospectus assessments, and government resources. 
 
INFORMATION SOURCES
 
Information for this report was obtained from industry analysts; the Center for Medicare and Medicaid Services (CMS), the National Institutes of Health (NIH), the Centers for Disease Control (CDC) and other government agencies; the United Network for Organ Sharing; the Organ Procurement and Transplantation Network; the Scientific Registry of Transplant Recipients; literature searches; companies’ annual reports and 10Ks; and product literature.
 
AUTHOR'S  CREDENTIALS
 
Vicki McConnell and Peggy Lehr were the BCC Research co-project directors of this report. Collectively, they have more than 40 years of medical industry experience. Ms. McConnell has written numerous reports and textbook entries on medical equipment components, materials, and manufacturing methods. Ms. Lehr specializes in marketing reports for a variety of industries. Their most recent BCC Research report covered Medical Diagnostic Kits.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Organ and Tissue Transplantation and Alternatives 273Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY2Free
Chapter- 3: INDUSTRY OVERVIEW29Free
Chapter- 4: GOVERNMENT REGULATIONS3Free
Chapter- 5: TRANSPLANTATION PRODUCTS AND PHARMACEUTICALS35Free
Chapter- 6: PROCUREMENT AND HARVESTING12Free
Chapter- 7: SOLID ORGAN TRANSPLANTATION50Free
Chapter- 8: TISSUE TRANSPLANTATION56Free
Chapter- 9: ALTERNATIVES TO DONOR TRANSPLANTATION46Free
Chapter- 10: C. CRAMER & CO. GMBH36Free
Published - Oct-2005| Analyst - Lynn Gray| Code - HLC012C

Report Highlights

  • The organ and tissue transplantation market in the U.S. is estimated at $11.7 billion in 2005 ad is expected to rise at an average annual growth rate (AAGR) of 5.2% to $15.1 billion by 2010.
  • The transplantation market is estimated at just under $5 billion in 2005 and is expanding at an AAGR of 4.8%.
  • The fastest growing sector is small bowel (intestine) transplantation. Kidney and liver transplantation will account for 78% of the total in 2005.
  • The U.S. tissue transplantation market totaled about $6.8 billion in 2005. It is projected to grow at an AAGR of 5.5%, to $8.9 billion in 2010.
Published - Mar-2003| Analyst - Peter Downs| Code - HLC012B

Report Highlights

  • Tissue and organ transplantation in the U.S. was a $17.3 billion market in 2002.
  • This is expected to grow 18% to $20.5 billion by 2007 at an average annual rate (AAGR) of 3.5%.
  • The fastest growing sector is small bowel transplantation.
  • Kidney transplantation accounted for 59% of U.S. organ transplants in 2002.

Related Reports

Recent Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

World Markets for Fermentation Ingredients

Published - Nov 2022 | Publisher - BCC Publishing | Code - FOD020G

The global fermentation-derived fine chemicals market should reach $42.4 billion by 2027 from $32.0 billion in 2022 at a compound annual growth rate (CAGR) of 5.8% for the forecast period of 2022 to 2027.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Seawater and Brackish Water Desalination

Published - Nov 2022 | Publisher - BCC Publishing | Code - MST052E

The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Organ and Tissue Transplantation and Alternatives
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, MA for over 50 years, we are your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, to better understand their field and target audience. We are dedicated to helping companies access reliable information, accurate forecasts, and actionable insights, to become leaders in their industry.
Contact
© 2024 BCC Research
Privacy Policy |Site Map|Terms & Conditions